July 27, 2012
July 27, 2012 —
Using a new assay method to study tumor cells, researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center have found evidence of clonal evolution in chronic lymphocytic leukemia (CLL). The assay method distinguishes features of leukemia cells that indicate whether the…
November 24, 2021
November 24, 2021 —
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
September 27, 2017
September 27, 2017 —
Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors. Instead of targeting mutant KRAS itself, researchers at University of California San Diego School of Medicine are now looking…
February 7, 2023
February 7, 2023 —
A novel drug combination for leukemia, pioneered at UC San Diego Health, provides patients with a better treatment option that results in less side effects and can put patients in remission.
April 24, 2019
April 24, 2019 —
Researchers at University of California San Diego School of Medicine found using blood thinners in patients with worsening heart failure, coronary artery disease and irregular heart rhythms was associated with a reduced risk of thromboembolic events, such as stroke and heart attack.
April 20, 2014
April 20, 2014 —
Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered a biomarker called CD61 on the surface of drug-resistant tumors that appears responsible for inducing tumor metastasis by enhancing…
December 16, 2015
December 16, 2015 —
UC San Diego Health and the City of El Centro have entered the next phase of a comprehensive management services relationship with El Centro Regional Medical Center (ECRMC). Under a new agreement, UC San Diego Health will provide strategic planning and management and consulting services to the ECRMC Board of…
August 18, 2022
August 18, 2022 —
New medication now available at UC San Diego Health allows for less frequent visits for patients, helping improve quality of life.
August 12, 2021
August 12, 2021 —
UC San Diego researchers develop a method to grow hematopoietic stem cells in culture, with clinical implications for bone marrow transplants and aging research.
August 11, 2014
August 11, 2014 —
During pregnancy, certain hormones trigger specialized mammary stem cells to create milk-producing cells essential to lactation. Scientists at the University of California, San Diego School of Medicine and Moores Cancer Center have found that mammary stem cells associated with the pregnant mammary gland are related to stem cells found in…